Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
01/29 BIOCON : Jeremy Levin: Teva is continuing my focus
01/28 TEVA PHARMACEUTICAL : Investors Sell Teva Pharmaceutical Industries Ltd (ADR) on..
01/27 Still looking to buy, Pfizer revenue, profit hit by currency-exchange rates
01/26 TEVA PHARMACEUTICAL : Receives FDA Approval for First Generic Nexium® Delayed-Re..
01/26DJFDA Rejects Antares' Application for Generic Migraine Drug
01/21 TEVA PHARMACEUTICAL : US Supreme Court sides with Teva in drug dispute
01/21 TEVA PHARMACEUTICAL : US Supreme Court rules for Teva
01/20DJADR Shares End Mixed; SAP Shares Fall
01/20DJSupreme Court Sides With Teva in Patent Case on Copaxone -- 2nd Update
01/20DJSupreme Court Sides With Teva in Patent Case on Copaxone -- 2nd Update
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF